JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 8, 2007; DOI: 10.1124/jpet.106.118786


0022-3565/07/3213-1075-1084$20.00
JPET 321:1075-1084, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.118786v1
321/3/1075    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saleh, S. N.
Right arrow Articles by Greenwood, I. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saleh, S. N.
Right arrow Articles by Greenwood, I. A.

CARDIOVASCULAR

Stimulation of Ca2+-Gated Cl- Currents by the Calcium-Dependent K+ Channel Modulators NS1619 [1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and Isopimaric Acid

Sohag N. Saleh, Jeff E. Angermann, William R. Sones, Normand Leblanc, and Iain A. Greenwood

Ion Channels and Cell Signaling Research Centre, Division of Basic Medical Sciences, St. George's, University of London, London, United Kingdom (S.N.S., W.R.S., I.G.); and Department of Pharmacology, Center of Biomedical Research Excellence, University of Nevada School of Medicine, Reno, Nevada (J.E.A., N.L.)

Because chloride (Cl-) channel blockers such as niflumic acid enhance large-conductance Ca2+-activated potassium channels (BKCa), the aim of this study was to determine whether there is a reciprocal modification of Ca2+-activated chloride Cl- currents (IClCa) by two selective activators of BKCa. Single smooth muscle cells were isolated by enzymatic digestion from murine portal vein and rabbit pulmonary artery. The BKCa activators NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl-)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and isopimaric acid (IpA) augmented macroscopic IClCa elicited by pipette solutions containing [Ca2+]i > 100 nM without any alteration in current kinetics. Enhanced currents recorded in the presence of NS1619 or IpA reversed at the theoretical Cl- equilibrium potential, which was shifted by approximately -40 mV upon replacement of the external anion with the more permeable thiocyanate anion. NS1619 increased the sensitivity of calcium-activated chloride channel (ClCa) to Ca2+ (~100 nM at +60 mV) and induced a leftward shift in their voltage dependence (~80 mV with 1 µMCa2+). Single-channel experiments revealed that NS1619 increased the number of open channels times the open probability of small-conductance (1.8–3.1 pS) ClCa without any alteration in their unitary amplitude or number of observable unitary levels of activity. These data, in addition to the established stimulatory effects of niflumic acid on BKCa, show that there is similarity in the pharmacology of calcium-activated chloride and potassium channels. Although nonspecific interactions are possible, one alternative hypothesis is that the channel underlying vascular IClCa shares some structural similarity to the BKCa or that the latter K+ channel physically interacts with ClCa.


Received December 19, 2006; accepted March 5, 2007.

Address correspondence to: Dr. Iain A. Greenwood, Ion Channels and Cell Signaling Research Centre, Division of Basic Medical Sciences, St. George's, University of London, SW17 0RE London, UK. E-mail: i.greenwood{at}sgul.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.